Diana Ernst, RPh

Editorial Director

Diana Ernst, RPh, is the Editorial Director for MPR, part of the Haymarket Medical Network. Since 2003, Diana has worked to provide healthcare professionals with up-to-date drug information through MPR's print and digital offerings. She is a graduate of the Ernest Mario School of Pharmacy, Rutgers University.

All articles by Diana Ernst, RPh

Infectious Diseases Information Center

Vaccines for Monkeypox Prevention: Jynneos and ACAM2000

Brian Park, PharmD

Diana Ernst, RPh

August 4, 2022

An individual is considered fully vaccinated about 2 weeks after the second dose of Jynneos and 4 weeks after receiving ACAM2000.

Infectious Diseases Information Center

Monkeypox Testing: Lesion Swab Samples Should Be Used

Diana Ernst, RPh

July 19, 2022

The Agency warned that use of an alternate sample type (eg, blood, saliva) may lead to false test results.

Infectious Diseases Information Center

FDA Authorizes COVID-19 Vaccines for Children as Young as 6 Months

Diana Ernst, RPh

June 21, 2022

The FDA evaluation included an analysis of safety, effectiveness and manufacturing data of these vaccines.

Neurology Information Center

Gabapentin-Involved Overdose Deaths Increased Between 2019 and 2020

Diana Ernst, RPh

June 2, 2022

Researchers used data from the State Unintentional Drug Overdose Reporting System in order to assess trends in gabapentin-involved overdose deaths.

Infectious Diseases Information Center

CDC Issues Guidance on COVID-19 Rebound After Paxlovid Treatment

Diana Ernst, RPh

May 25, 2022

Recent case reports suggest that some patients treated with Paxlovid may have a recurrence of COVID-19 symptoms 2 to 8 days after completing the 5-day course.

Pain Information Center

FDA Considers Mail-Back Envelope as New Disposal Method for Opioids

Diana Ernst, RPh

April 26, 2022

The Agency is currently seeking public comment on this potential modification to the existing Opioid Analgesic Risk Evaluation and Mitigation Strategy.